Feedback

State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach

Affiliation
South African Medical Research Council Bioinformatics Unit ,South African National Bioinformatics Institute ,University of the Western Cape ,Cape Town ,South Africa
Akinnuwesi, Adetutu;
Affiliation
School of Pharmacy ,University of the Western Cape ,Cape Town ,South Africa
Egieyeh, Samuel;
Affiliation
South African Medical Research Council Bioinformatics Unit ,South African National Bioinformatics Institute ,University of the Western Cape ,Cape Town ,South Africa
Cloete, Ruben

Tuberculosis remains one of the causes of death from a single infectious bacterium. The inappropriate use of antibiotics and patients’ non-compliance among other factors drive the emergence of drug-resistant tuberculosis. Multidrug-resistant and extensively drug-resistant strains of tuberculosis pose significant challenges to current treatment regimens, as their reduced efficacy against these strains limits successful patient outcomes. Furthermore, the limited effectiveness and associated toxicity of second-line drugs further compound the issue. Moreover, the scarcity of novel pharmacological targets and the subsequent decline in the number of anti-TB compounds in the drug development pipeline has further hindered the emergence of new therapies. As a result, researchers need to develop innovative approaches to identify potential new anti-TB drugs. The evolution of technology and the breakthrough in omics data allow the use of computational biology approaches, for example, metabolomic analysis to uncover pharmacological targets for structured-based drug design. The role of metabolism in pathogen development, growth, survival, and infection has been established. Therefore, this review focuses on the M. tb metabolic network as a hub for novel target identification and highlights a step-by-step subtractive genomics approach for target prioritization.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Akinnuwesi, Egieyeh and Cloete.

Use and reproduction: